CRISPONI, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 171.861
NA - Nord America 10.478
AS - Asia 1.408
AF - Africa 19
OC - Oceania 14
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 183.794
Nazione #
IT - Italia 168.869
US - Stati Uniti d'America 10.392
UA - Ucraina 1.120
CN - Cina 962
SE - Svezia 615
DE - Germania 457
GB - Regno Unito 282
SG - Singapore 277
FI - Finlandia 275
FR - Francia 90
CA - Canada 77
RU - Federazione Russa 43
IN - India 42
KR - Corea 36
VN - Vietnam 31
IR - Iran 28
BE - Belgio 23
NL - Olanda 15
AU - Australia 14
ES - Italia 14
CH - Svizzera 8
IE - Irlanda 8
MX - Messico 8
BR - Brasile 7
MU - Mauritius 7
CZ - Repubblica Ceca 6
RO - Romania 6
TR - Turchia 6
AT - Austria 5
EG - Egitto 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
JP - Giappone 4
GR - Grecia 3
PE - Perù 3
SY - Repubblica araba siriana 3
BG - Bulgaria 2
DZ - Algeria 2
EU - Europa 2
ID - Indonesia 2
IQ - Iraq 2
IS - Islanda 2
MA - Marocco 2
MN - Mongolia 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BW - Botswana 1
EC - Ecuador 1
GD - Grenada 1
HK - Hong Kong 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TW - Taiwan 1
VE - Venezuela 1
Totale 183.794
Città #
Cagliari 165.613
Uta 2.527
Fairfield 1.439
Woodbridge 1.072
Houston 801
Chandler 767
Ashburn 724
Wilmington 608
Jacksonville 604
Ann Arbor 597
Boardman 579
Seattle 551
Cambridge 508
Nyköping 439
Dearborn 295
Nanjing 194
Singapore 151
Boston 149
Helsinki 107
Santa Clara 101
Beijing 100
Shanghai 82
San Diego 70
Escalaplano 69
Nanchang 69
New York 68
Shenyang 56
Hebei 52
Milan 52
Redwood City 52
Guangzhou 51
Jiaxing 43
Changsha 42
Toronto 41
Tianjin 38
Verona 36
Los Angeles 35
Mountain View 34
Norwalk 33
Dong Ket 30
Orange 29
Seoul 29
Atlanta 28
Sassari 28
Zhengzhou 27
Jinan 26
Ottawa 24
Brussels 23
Ningbo 22
London 21
Hefei 18
Auburn Hills 17
Cedar Knolls 16
Pars 16
Pune 15
Bari 12
Rome 12
Washington 12
Falls Church 11
Hangzhou 11
Redmond 8
Sinalunga 8
Spin 8
Taizhou 8
Dublin 7
Fuzhou 7
Kilburn 7
Altedo 6
Borås 6
Chicago 6
Florence 6
Kunming 6
San Mateo 6
Bologna 5
Dallas 5
Iglesias 5
Messina 5
Padova 5
Phoenix 5
Saint Petersburg 5
Wuhan 5
Acerra 4
Bergamo 4
Chengdu 4
Genoa 4
Indiana 4
Islington 4
Nitra 4
Paris 4
Perugia 4
Sacramento 4
Shaoxing 4
Shenzhen 4
Vancouver 4
Wuxi 4
Augusta 3
Bengaluru 3
Esslingen am Neckar 3
Forest City 3
Frankfurt am Main 3
Totale 179.476
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.629
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.727
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.512
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.428
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.392
Multiple Sclerosis and environmental factors. 3.176
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.827
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.681
The essential metals for humans: a brief overview 2.572
Looking at new ligands for chelation therapy 2.416
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.299
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.279
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.166
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.125
Do anti-diabetic drugs act as copper ligands? 2.104
Gold nanoparticles: A new golden Era in oncology? 2.103
Toxicity of nanoparticles: etiology and mechanisms 2.088
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.085
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 1.993
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 1.966
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 1.943
Arsenic toxicity: Molecular targets and therapeutic agents 1.917
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.898
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 1.884
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.877
Kill or cure: Misuse of chelation therapy for human diseases 1.841
The meaning of aluminium exposure on human health and aluminium-related diseases 1.829
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.824
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.811
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.806
Silver coordination compounds: A new horizon in medicine 1.781
Alarming use of chelation therapy 1.766
Chemical features of in use and in progress chelators for iron overload 1.755
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.748
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.729
State of art in chelating agents for the clinical treatment of metal poisoning 1.724
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.719
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.709
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.694
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.679
Chelating agents as therapeutic compounds - Basic principles 1.648
Noble metals in medicine: Latest advances 1.640
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.616
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.604
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.546
Uneven hepatic copper distribution in Wilson's disease 1.514
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.472
Uneven cardiac iron distribution in beta-thalassemia 1.435
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips 1.362
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine 1.296
Chelating agents for metal intoxication 1.205
null 1.188
Metal ion toxicity 1.188
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.146
Iron chelating agents for iron overload diseases 1.136
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology 1.136
The Potential Clinical Properties of Magnesium 1.128
Warns against unapproved ‘chelation therapy’ 1.111
null 1.075
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.052
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.038
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson’s disease and beta-thalassemia 1.023
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.011
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.007
A new hydroxypyrone chelating agent for FeIII and AlIII: a structural and equilibrium study 988
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 957
Sampling variability in hepatic iron concentration in beta-thalassemia 950
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 945
Kojic derivatives: a promising class of iron(III) chelators 911
Enhancement of g-aminobutyric acid binding by Quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors 890
A spectroscopic study on ionization of 2-, 3- and 4-aminopyridines 882
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 863
null 845
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 841
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate 833
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications 814
Nickel binding sites in histone proteins: spectroscopic and structural characterization 810
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator 799
Preface 783
Anomalies of the oral cavity in newborns 783
A Chemometric analysis of metal ion content in Sardinian wines 768
Manganese and cobalt binding in a multi-histidinic fragment 755
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites 721
Stress and ß-carbolines decrease the density of low affinity Gaba binding sites; an effect reversed by diazepam 697
Calculation of spectra parameters in several spectra by contemporary decomposition in the constituent Gaussian peaks 680
null 678
Divalent metal-acetate complexes in concentrated aqueous solutions. An X-ray diffraction and NMR spectroscopy study 673
null 666
Changes in the characteristics of low affinity of Gaba binding sites elicited by Ro15-1788 648
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)] 638
SUBSTITUENT EFFECTS OF NITRO GROUP ON THE COMPLEX FORMATION EQUILIBRIA OF SALICYLIC ACID AND CATECHOL WITH Fe(III) AND Al(III) IONS 636
Equilibrium constants of the Fe(III)dopamine system in aqueous solution 623
Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues 620
null 598
Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease 590
Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)](n), [Cu(tda)(Him)(2)(H2O)] and [Cu(tda)(5Mphen)] center dot 2H(2)O (Him = imidazole, 5Mphen=5-methyl-1,10-phenanthroline) 586
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrais(mu(2)-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II) 584
State of art in the treatment of metal toxicity 575
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson and beta-thalassemia 573
THIODIACETATE-COPPER(II) CHELATES WITH OR WITHOUT N-HETEROCYCLIC DONOR LIGANDS. CRYSTAL STRUCTURES OF [CU(TDA)]N, [CU(TDA)(HIM)2(H2O)] AND [CU(TDA)(5MPHEN)].2H2O 572
Totale 147.854
Categoria #
all - tutte 234.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028.693 0 0 0 0 11.651 7.623 4.046 1.037 802 802 836 1.896
2020/202149.188 1.530 1.722 2.460 11.583 9.479 6.362 4.999 3.278 1.210 2.699 2.162 1.704
2021/20228.541 1.083 959 497 772 751 678 521 326 596 687 881 790
2022/202311.356 922 1.154 1.175 826 942 1.268 548 1.937 802 571 719 492
2023/202412.856 746 532 575 997 1.394 2.210 1.777 829 517 1.068 1.120 1.091
2024/202521.601 7.253 7.466 3.352 2.552 978 0 0 0 0 0 0 0
Totale 184.209